Search Results

There are 7526291 results for: content related to: Dapsone for refractory chronic idiopathic thrombocytopenic purpura

  1. Use of a metabolic inhibitor to reduce dapsone-dependent haematological toxicity

    Drug Development Research

    Volume 25, Issue 1, 1992, Pages: 1–16, Michael Damian Coleman and Malcolm Drummond Tingle

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430250102

  2. Inhibition of Dapsone-induced Methaemoglobinaemia by Cimetidine in the Presence of Trimethoprim in the Rat

    Journal of Pharmacy and Pharmacology

    Volume 44, Issue 2, February 1992, Pages: 114–118, M. D. COLEMAN, R. M. RUSSELL, M. D. TINGLE and B. K. PARK

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1992.tb03573.x

  3. You have free access to this content
    The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.

    British Journal of Clinical Pharmacology

    Volume 34, Issue 3, September 1992, Pages: 244–249, MD Coleman, LE Rhodes, AK Scott, JL Verbov, PS Friedmann, AM Breckenridge and BK Park

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1992.tb04131.x

  4. Adjuvant therapy of bullous pemphigoid with dapsone

    Clinical and Experimental Dermatology

    Volume 14, Issue 2, March 1989, Pages: 132–136, E.W.B. JEFFES III and A.R. AHMED

    Version of Record online : 27 APR 2006, DOI: 10.1111/j.1365-2230.1989.tb00910.x

  5. Development of dapsone toxicity in patients with inflammatory dermatoses: Activity of acetylation and hydroxylation of dapsone as risk factors

    Clinical Pharmacology & Therapeutics

    Volume 65, Issue 6, June 1999, Pages: 598–605, Ranata E. Bluhm, Adedayo Adedoyin, D. G. McCarver and Robert A. Branch

    Version of Record online : 17 JUN 1999, DOI: 10.1016/S0009-9236(99)90081-4

  6. Improving adherence to safe prescription guidelines for Dapsone: harnessing an enhanced electronic medical records system and a team approach

    International Journal of Dermatology

    Volume 51, Issue 3, March 2012, Pages: 349–354, Ching Yin Neoh, Elizabeth A.L. Tian, Cindy Choi, Hui Hui Leong, Audrey W.H. Tan and Roy K.W. Chan

    Version of Record online : 20 FEB 2012, DOI: 10.1111/j.1365-4632.2011.05217.x

  7. Inhibition of Dapsone-Induced Methaemoglobinaemia by Cimetidine in the Rat During Chronic Dapsone Administration

    Journal of Pharmacy and Pharmacology

    Volume 43, Issue 3, March 1991, Pages: 186–190, M. D. COLEMAN, M. D. TINGLE and B. K. PARK

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1991.tb06663.x

  8. Dapsone in Behçet's Disease: A Double-Blind, Placebo-Controlled, Cross-Over Study

    The Journal of Dermatology

    Volume 29, Issue 5, May 2002, Pages: 267–279, Khalifa E. Sharquie, Rafid A. Najim and Ahmed R. Abu-Raghif

    Version of Record online : 22 JUL 2014, DOI: 10.1111/j.1346-8138.2002.tb00263.x

  9. Cost–utility analysis in acute ischemic stroke survivors treated with dapsone in a public hospital in Mexico City

    Journal of Pharmaceutical Health Services Research

    Volume 5, Issue 2, June 2014, Pages: 95–102, Copytzy Cruz-Cruz, Jaime Kravzov-Jinich, Juan Manuel Martínez-Núñez, Camilo Ríos-Castañeda, Mirza E. Perez and Marina Altagracia-Martínez

    Version of Record online : 29 APR 2014, DOI: 10.1111/jphs.12052

  10. Erythema elevatum diutinum: a review of presentation and treatment

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 12, December 2014, Pages: 1594–1602, S.E. Momen, J. Jorizzo and F. Al-Niaimi

    Version of Record online : 7 OCT 2014, DOI: 10.1111/jdv.12566

  11. Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data

    Clinical Microbiology and Infection

    Volume 2, Issue 1, August 1996, Pages: 30–35, M. Cruciani, E. Bertazzoni Minelli, M. Mirandola, R. Luzzati, M. Merighi, L. Lazzarini, G. Gatti, S. Vento, R. Mazzi, M. Malena, A. Benini, A. Cazzadori, G. Piemonte, D. Bassetti and E. Concia

    Version of Record online : 5 JAN 2011, DOI: 10.1111/j.1469-0691.1996.tb00197.x

  12. Gonadal Influence on the Metabolism and Haematological Toxicity of Dapsone in the Rat

    Journal of Pharmacy and Pharmacology

    Volume 42, Issue 10, October 1990, Pages: 698–703, M. D. COLEMAN, M. D. TINGLE, M. J. WINN and B. K. PARK

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1990.tb06562.x

  13. Antibiotics used in nonbacterial dermatologic conditions

    Dermatologic Therapy

    Volume 25, Issue 1, January/February 2012, Pages: 38–54, RACHEL A. GORDON, RANA MAYS, BRITTANY SAMBRANO, TIFFANY MAYO and WHITNEY LAPOLLA

    Version of Record online : 16 MAY 2012, DOI: 10.1111/j.1529-8019.2012.01496.x

  14. The disposition of dapsone in cirrhosis

    Clinical Pharmacology & Therapeutics

    Volume 51, Issue 6, June 1992, Pages: 689–700, D Gail May, Patricia A Arns, William O Richards, James Porter, Diane Ryder, Carolyn M Fleming, Grant R Wilkinson and Robert A Branch

    Version of Record online : 14 JUN 1992, DOI: 10.1038/clpt.1992.81

  15. The Effect of Phytosterols on Quality of Life in the Treatment of Benign Prostatic Hyperplasia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 11, November 2002, Pages: 1420–1425, Dr. Craig I. Coleman, John H. Hebert and Prabashni Reddy

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.22.16.1420.33698

  16. The Effect of Acetylation and Deacetylation on the Disposition of Dapsone and Monoacetyl Dapsone Hydroxylamines in Human Erythrocytes In-vitro

    Journal of Pharmacy and Pharmacology

    Volume 48, Issue 4, April 1996, Pages: 401–406, MICHAEL D. COLEMAN, KULDIP KAUR PAHAL and JOHN M. GARDINER

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1996.tb05941.x

  17. Delayed administration of dapsone protects from tissue damage and improves recovery after spinal cord injury

    Journal of Neuroscience Research

    Volume 89, Issue 3, March 2011, Pages: 373–380, Araceli Diaz-Ruiz, Hermelinda Salgado-Ceballos, Sergio Montes, Gabriel Guizar-Sahagún, Noemi Gelista-Herrera, Marisela Mendez-Armenta, Sofia Diaz-Cintra and Camilo Ríos

    Version of Record online : 6 JAN 2011, DOI: 10.1002/jnr.22555

  18. The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects

    Clinical Pharmacology & Therapeutics

    Volume 48, Issue 6, December 1990, Pages: 619–627, D Gail May, James A Porter, Jack P Uetrecht, Grant R Wilkinson and Robert A Branch

    Version of Record online : 2 DEC 1990, DOI: 10.1038/clpt.1990.204

  19. You have free access to this content
    The use of cimetidine as a selective inhibitor of dapsone N- hydroxylation in man.

    British Journal of Clinical Pharmacology

    Volume 30, Issue 5, November 1990, Pages: 761–767, MD Coleman, AK Scott, AM Breckenridge and BK Park

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1990.tb03847.x

  20. Dapsone as first line therapy for bullous pemphigoid

    British Journal of Dermatology

    Volume 120, Issue 1, January 1989, Pages: 83–92, V.A. VENNING, P.R. MILLARD and F. WOJNAROWSKA

    Version of Record online : 29 JUL 2006, DOI: 10.1111/j.1365-2133.1989.tb07769.x